Skip to main content
Indian stocks: Visit www.stage2stocks.com →

The Joint Corp.

Stage 4 · Declining · week 11

As of Oct 22, 2026, Joint is in Stage 4, the downtrend phase, now in week 11 (since Aug 6, 2026). It closed at $7.37, 30.0% below its 52-week high and below its 200-day average, which is falling.

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. More about the company

$7.37
+2.79% today
$104M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is JYNT early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S1 13w
S2 18w
S4 16w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 18w → S1 13w → S2 18w → S3 8w → S4 9w → S1 5w → S4 10w → S1 6w → S4 10w → S1 3w → S2 5w → S3 2w → S4 16w → S1 10w → S4 11w → S1 5w → S2 3w → S4 11w current
Total tracked: 165 weeks across 18 stage runs.

JYNT among Medical Care Facilities34th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…34JYNTStage 4 · wk 1143−11.6%
vs 52W High
-30.0%
$6.90 lo$10.53 hi
30.0% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 11
1w13w26w
Week 11, established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-14.9%
200 DMA: $8.66 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.41x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-11.6%
3M
-11.7%
6M
-16.3%
YTD
-16.7%
1Y
-15.4%
Scan Membership
Breakout Watch
Latest: 2024-03-25
6 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 11 · Vol 0.41x
2026-10-21S4
Wk 11 · Vol 0.29x
2026-10-20S4
Wk 11 · Vol 0.48x
2026-10-19S4
Wk 11 · Vol 1.10x
2026-10-16S4
Wk 11 · Vol 0.57x
2026-10-15S4
Wk 10 · Vol 0.71x
2026-10-14S4
Wk 10 · Vol 1.28x
2026-10-13S4
Wk 10 · Vol 0.93x
2026-10-12S4
Wk 10 · Vol 0.49x
2026-10-09S4
Wk 10 · Vol 0.52x
2026-10-08S4
Wk 9 · Vol 0.98x
2026-10-07S4
Wk 9 · Vol 0.80x
Moving averages & range
50 DMA
$7.92
200 DMA
$8.66
52W High
$10.53
52W Low
$6.90
5D Low
$7.03
Resistance levels (recent highs)
20d High
$8.23
60d High
$8.68
120d High
$9.58
250d High
$10.53
Next resistance
+11.7%
to 20d High
P/E (TTM)
52.6
Forward 11.1
Earnings Growth (YoY)
+652.6%
Revenue +14.4%
ROE
+10.6%
Profit margin +6.5%
Dividend Yield
0.00%
P/B 6.4

Joint: quick answers

What stage is Joint in?

As of Oct 22, 2026, Joint (JYNT) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 6, 2026 and is in week 11. What the four stages mean

Is Joint in an uptrend?

No. Joint is in a Stage 4 downtrend. It trades 14.9% below its 200-day average, which is falling.

How far is Joint from its 52-week high?

Joint closed at $7.37 on Oct 22, 2026, 30.0% below its 52-week high of $10.53. Its 52-week low is $6.90.

How has Joint performed over the past year?

As of Oct 22, 2026, Joint is down 15.4% over the past year and down 16.7% so far in 2026.

Which sector and industry is Joint in?

Joint is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.